Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus.

Göbl, Christian S.; Bozkurt, Latife; Yarragudi, Rajashri; Prikoszovich, Thomas; Tura, Andrea; Pacini, Giovanni; Koppensteiner, Renate; Kautzky-Willer, Alexandra

Background History of gestational diabetes mellitus (GDM) identifies a very young population of females predisposed for type 2 diabetes and cardiovascular disease. Endothelial dysfunction might represent a shared precursor of both disorders. Hence, this study aimed to characterize endothelial biomarkers in relation to impaired insulin sensitivity and progression to overt diabetes early after index pregnancy. Methods 108 women with previous GDM and 40 controls were included three to six months after delivery and underwent specific metabolic assessments including a frequently sampled intravenous glucose tolerance test and an oral glucose tolerance test. Diabetes progression was assessed in females with pGDM over 10 years of follow-up. Circulating sICAM-1 (intracellular-adhesion-molecule-1), sVCAM-1 (vascular-cell-adhesion-molecule-1) and sEselectin, representing biomarkers of endothelial dysfunction were assessed at baseline and annually over five years. Results Endothelial biomarkers were significantly associated with insulin sensitivity (sICAM-1: rSpearman = -0.23, p =0.009; sVCAM-1: rSpearman = -0.22, p =0.011; sE-selectin: rSpearman = -0.21, p =0.018) as well as with GDM status and parameters of subtle inflammation. Analysis of long-term trajectories revealed constantly elevated sICAM-1 (p =0.033) and sEselectin (p =0.007) in 25 subjects with diabetes progression. Accordingly, sE-selectin levels at the early post partum visit predicted a later development of the disease (HR =1.02 95%CI 1.01 to 1.04, p =0.009), however, this was attenuated after adjustment for BMI. Conclusions Elevated circulating markers of endothelial dysfunction in young females with GDM history might reflect an early stage on the pathway to the manifestation of future cardiometabolic disorders. Timely identification of women at high risk and optimization of follow-up management might provide an opportunity to prevent disease progression.

BIOMARKERS; CARBOHYDRATE metabolism; DIABETES; GESTATIONAL diabetes; DISEASE progression; BODY mass index

Cardiovascular Diabetology, 2014, Vol 13, Issue 1, p1

1475-2840

Academic Journal

10.1186/s12933-014-0138-3